Adagio Medical Holdings (ADGM) Operating Margin (2023 - 2024)
Adagio Medical Holdings' (ADGM) quarterly Operating Margin came in at 3352.27% in Q3 2024, up 1879651.0% year-over-year from N/an in Q4 2023, and down 27.87% quarter-over-quarter from 2621.65% in Q2 2024.
Powered by 
Analysis
Adagio Medical Holdings (ADGM) Operating Margin (2023 - 2024) Analysis & Trends
Adagio Medical Holdings has disclosed Operating Margin across 2 years of filings, most recently posting 3352.27% for Q3 2024.
- In Q3 2024, Operating Margin rose 1879651.0% year-over-year to 3352.27%; the TTM figure through Sep 2025 stood at 16863.64% (down 1171425.0% YoY), while the FY2024 annual figure was 23226.77%, down 1391277.0% from the prior year.
- Operating Margin came in at 3352.27% for Q3 2024 at Adagio Medical Holdings, down from 2621.65% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 2621.65% in Q2 2024 to a low of 33903.85% in Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 19.15% |
| 10 | Adagio Medical Holdings | 12.44 Mn | 12.44 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | -3,352.27% |
| Jun 30, 2024 | -2,621.65% |
| Mar 31, 2024 | -33,903.85% |
| Dec 31, 2023 | -6,837.18% |
| Sep 30, 2023 | -22,148.78% |